“A Phase 1 trial in China has demonstrated the safety of a new Ebola vaccine and hinted at its efficacy, according to a study published today (March 25) in The Lancet. The vaccine candidate is the first to incorporate immunogens from the strain of Ebola that has terrorized West Africa for nearly a year; all other tested Ebola vaccines have been based on the strain that caused an outbreak in Zaire in 1976, according to a press release.”
Friday, March 27, 2015
Subscribe to:
Post Comments (Atom)
Posts
1 comment:
Gonna need it quick in Indiana. The epidemic in Scott County demonstrates that. And guess what, they are white people, and they mostly have no health insurance, and can't get any.
Post a Comment